Evidence map›Paper›PMID 35011353›Full record

ArticleMolecules (Basel, Switzerland)2021

Oenothein B in Eucalyptus Leaf Extract Suppresses Fructose Absorption in Caco-2 Cells.

Keiichiro Sugimoto, Midori Amako, Hiroaki Takeuchi, Kazuya Nakagawa, Morio Yoshimura, Yoshiaki Amakura, Tomoyuki Fujita, Shigeo Takenaka, Hiroshi Inui

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Keiichiro SugimotoResearch and Development Center, Nagaoka Co., Ltd., Ibaraki, Osaka 567-0005, Japan.ORCID 0000-0003-2927-1237
Midori AmakoCenter for Research and Development of Bioresources, Osaka Prefecture University, Sakai, Osaka 599-8570, Japan.
Hiroaki TakeuchiResearch and Development Center, Nagaoka Co., Ltd., Ibaraki, Osaka 567-0005, Japan.
Kazuya NakagawaResearch and Development Center, Nagaoka Co., Ltd., Ibaraki, Osaka 567-0005, Japan.
Morio YoshimuraDepartment of Pharmacognosy, College of Pharmaceutical Sciences, Matsuyama University, Ehime, Matsuyama 790-8578, Japan.
Yoshiaki AmakuraDepartment of Pharmacognosy, College of Pharmaceutical Sciences, Matsuyama University, Ehime, Matsuyama 790-8578, Japan.
Tomoyuki FujitaDepartment of Agriculture, Graduate School of Science and Technology, Shinshu University, Nagano 399-4598, Japan.
Shigeo TakenakaDepartment of Nutrition, College of Health and Human Sciences, Osaka Prefecture University, Habikino, Osaka 583-8555, Japan.
Hiroshi InuiDepartment of Nutrition, College of Health and Human Sciences, Osaka Prefecture University, Habikino, Osaka 583-8555, Japan.
Nagaoka University · JPOsaka Prefecture University · JPMatsuyama University · JPShinshu University · JP

Funding

The food industry sector of the Ministry of Agriculture, Forestry and Fisheries No numberThe Japan Science and Technology Agency No number
6 · The paper itself

Abstract

Inhibition of fructose absorption may suppress adiposity and adiposity-related diseases caused by fructose ingestion. Eucalyptus leaf extract (ELE) inhibits intestinal fructose absorption (but not glucose absorption); however, its active compound has not yet been identified. Therefore, we evaluated the inhibitory activity of ELE obtained from

Indexed as

Caco-2 CellsCell Membrane PermeabilityEucalyptusFructoseGlucose Transport Proteins, FacilitativeHumansHydrolyzable TanninsIntestinal AbsorptionIntestinesPlant ExtractsPlant LeavesPolyphenolsPovidoneellagitanninFructoseGlucose Transport Proteins, FacilitativeHydrolyzable Tanninsoenothein BPlant ExtractsPolyphenolspolyvinylpolypyrrolidonePovidoneCaco-2 cellellagitannineucalyptus leaf extractfructose absorptionglucose transporter 5hydrolyzable tanninsoenothein Bpolyphenolpolyvinylpolypyrrolidone

Identifiers

PMID35011353
PMCPMC8746427
OpenAlexW4200256550

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.